Medium having an altered porosity and membrane for the tangential flow filtration of a fluid

Details for Australian Patent Application No. 2005243842 (hide)

Owner Technologies Avancees et Membranes Industrielles

Inventors Lescoche, Philippe

Agent Davies Collison Cave

Pub. Number AU-B-2005243842

PCT Pub. Number WO2005/110583

Priority 0404307 23.04.04 FR

Filing date 21 April 2005

Wipo publication date 24 November 2005

Acceptance publication date 23 September 2010

International Classifications

B01D 61/14 (2006.01) Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration - Ultrafiltration

B01D 63/06 (2006.01) Apparatus in general for separation processes using semi-permeable membranes - Tubular membrane modules

B01D 67/00 (2006.01) Processes specially adapted for manufacturing semi-permeable membranes for separation processes or apparatus

B01D 69/10 (2006.01) Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties

B01D 71/02 (2006.01) Semi-permeable membranes for separation processes or apparatus characterised by the material

C04B 38/00 (2006.01) Porous mortars, concrete, artificial stone or ceramic ware

Event Publications

16 November 2006 PCT application entered the National Phase

  PCT publication WO2005/110583 Priority application(s): WO2005/110583

23 September 2010 Application Accepted

  Published as AU-B-2005243842

20 January 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005243851-Cyclonic separating apparatus

2005243834-Camptothecin derivatives conjugated in position 20 with integrin antagonists